News
2025/03/04
Announcements
Mitsubishi UFJ Capital and AGC Sign a Mandate Agreement for the Technical Evaluation of Drug Manufacturing for Investment Activities in Drug Discovery Start-ups
Mitsubishi UFJ Capital Co., Ltd.（Mitsubishi UFJ Capital; President: Takuro Kojima, Headquarters: Tokyo）and AGC Inc. (AGC; President: Yoshinori Hirai, Headquarters: Tokyo）have signed a mandate agreement for the technical evaluation of drug manufacturing, as part of Mitsubishi UFJ Capital's investment activities in drug discovery startups, etc.
For more information, please see attached PDF